| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
From the Pathology Division, National Cancer Center Research Institute, Tokyo, Japan
In a search for signaling molecules that act downstream of E-cadherin inactivation in cancer, we examined the expression and localization of E-cadherin-associated proteins in lobular carcinoma, in which the E-cadherin gene is frequently inactivated, and found that E-cadherin down-regulation correlated with the cytoplasmic localization of p120ctn. Similar cytoplasmic localization of p120ctn and growth factor-induced accumulation of tyrosine-phosphorylated p120ctn in the protrusive domain were observed in E-cadherin-deficient breast cancer cells. Down-regulation of endogenous p120ctn by RNA interference promoted stress fiber formation and induced a flattened morphology with an increase of Rho-GTPase activity; it also reduced the development of membranous protrusions and migratory activity in E-cadherin-deficient breast cancer cells. Inactivation of E-cadherin in cancer cells is associated with the conversion from epithelial to mesenchymal phenotype, which also occurs in physiological conditions such as developmental processes. Cytoplasmic localization of p120ctn accompanied by E-cadherin down-regulation was observed in mesoderm cells that had undergone epithelial-mesenchymal transition during early mouse embryogenesis. Collectively, our results suggest that cytoplasmic p120ctn may contribute to the invasive phenotype of E-cadherin-deficient breast cancer cells.
This article has been cited by other articles:
 |
|
 |
|
  Y. Arima, Y. Inoue, T. Shibata, H. Hayashi, O. Nagano, H. Saya, and Y. Taya Rb Depletion Results in Deregulation of E-Cadherin and Induction of Cellular Phenotypic Changes that Are Characteristic of the Epithelial-to-Mesenchymal Transition Cancer Res., July 1, 2008; 68(13): 5104 - 5112. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J Paredes, A L Correia, A S Ribeiro, F Milanezi, J Cameselle-Teijeiro, and F C Schmitt Breast carcinomas that co-express E- and P-cadherin are associated with p120-catenin cytoplasmic localisation and poor patient survival J. Clin. Pathol., July 1, 2008; 61(7): 856 - 862. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Boguslavsky, I. Grosheva, E. Landau, M. Shtutman, M. Cohen, K. Arnold, E. Feinstein, B. Geiger, and A. Bershadsky p120 catenin regulates lamellipodial dynamics and cell adhesion in cooperation with cortactin PNAS, June 26, 2007; 104(26): 10882 - 10887. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Strumane, A. Bonnomet, C. Stove, R. Vandenbroucke, B. Nawrocki-Raby, E. Bruyneel, M. Mareel, P. Birembaut, G. Berx, and F. van Roy E-Cadherin Regulates Human Nanos1, which Interacts with p120ctn and Induces Tumor Cell Migration and Invasion. Cancer Res., October 15, 2006; 66(20): 10007 - 10015. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. T. Fox, C. C. F. Homem, S. H. Myster, F. Wang, E. E. Bain, and M. Peifer Rho1 regulates Drosophila adherens junctions independently of p120ctn Development, November 1, 2005; 132(21): 4819 - 4831. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Hayashida, K. Honda, M. Idogawa, Y. Ino, M. Ono, A. Tsuchida, T. Aoki, S. Hirohashi, and T. Yamada E-Cadherin Regulates the Association between {beta}-Catenin and Actinin-4 Cancer Res., October 1, 2005; 65(19): 8836 - 8845. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Furukawa, Y. Daigo, N. Ishikawa, T. Kato, T. Ito, E. Tsuchiya, S. Sone, and Y. Nakamura Plakophilin 3 Oncogene as Prognostic Marker and Therapeutic Target for Lung Cancer Cancer Res., August 15, 2005; 65(16): 7102 - 7110. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Huang, J. Groth, K. Sossey-Alaoui, L. Hawthorn, S. Beall, and J. Geradts Aberrant Expression of Novel and Previously Described Cell Membrane Markers in Human Breast Cancer Cell Lines and Tumors Clin. Cancer Res., June 15, 2005; 11(12): 4357 - 4364. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Soubry, J. van Hengel, E. Parthoens, C. Colpaert, E. Van Marck, D. Waltregny, A. B. Reynolds, and F. van Roy Expression and Nuclear Location of the Transcriptional Repressor Kaiso Is Regulated by the Tumor Microenvironment Cancer Res., March 15, 2005; 65(6): 2224 - 2233. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
